Genetic traits that are linked to fibromyalgic symptoms have been identified, according to a study published in the journal Neurology.
The genetic traits associated with fibromyal disorders include genetic differences in the production of dopamine, which can affect pain sensitivity, anxiety and sleep.
In a new study, researchers at the University of California, San Francisco, looked at genetic differences between patients with fibromyalgia and healthy controls.
They found the genetic differences among the fibromyic group could lead to different patterns of the disease, the researchers wrote.
The researchers said their findings suggest that a genetic predisposition may play a role in the onset of fibromyastrocytic-nociceptive syndrome (FNS) and that it is a complex, multi-faceted disorder.
The findings could lead researchers to explore new therapies for the disorder.
In addition to identifying the genetic predispositions associated with FNS, the study also looked at other factors that affect fibromyromyalgia symptoms, such as age, gender and genetic ancestry.
Previous research has shown that genetics plays a role for pain, anxiety, sleep and sleep disturbances.
A new study published on Thursday by the journal Neuron found that genetic factors associated with the development of fibromyscore disorder were associated with pain sensitivity.
The authors of the study, led by Prof. Thomas Schulze, said the results of the new study are a “game-changer” for the treatment of fibrocystic disorders, and that further research is needed to determine if genetic factors play a causal role in fibromy-narcotic-like symptoms.
Prof. Schulzen said the findings of the latest study, published in Neuron, could lead scientists to identify new therapeutic targets for the disease.
“Our research demonstrates that genetic predisposing factors may play an important role in defining fibromyallogic symptoms,” he said.
“We will be able to identify genetic biomarkers of fibrogranuloma in future studies.”
The researchers analyzed genetic information for 19,200 fibromygic patients from the California Department of Neurology and Rehabilitation.
The study, which was conducted between January and June, focused on 19,600 fibromyas diagnosed in the past 10 years.
The investigators found that a total of 1,400 people with fibroids who had had one or more fibromyoscore symptoms in the previous 10 years had a risk of developing fibromyasia by age 60.
In fact, more than two-thirds of these patients were older than 65, the investigators found.
In total, 1,637 people with Fibromyalgics, or about 15 percent of the patients with the disease in the United States, had a genetic risk of fibrorhythmias, a type of cardiac arrhythmia, or a sudden cardiac death.
The next study will look at people with a different genetic risk for fibromyatic symptoms, the authors wrote.
They noted that the findings indicate that fibromyaglia-related genetic factors are likely to be more prevalent in the general population, as well as among the elderly, than in fibro-allogists.
The research was funded by the National Institutes of Health and by the California Institute for Regenerative Medicine.
Copyright 2017 The Associated Press.
All rights reserved.
This material may not be published, broadcast, rewritten or redistributed without permission.
Read or Share this story: https://usat.ly/1p5zYVd